CRANBURY, N.J.--(BUSINESS WIRE)--July 27, 2006--Valera Pharmaceuticals (NASDAQ:VLRX - News), a specialty pharmaceutical company focused on the development, acquisition and commercialization of products for the urology and endocrinology markets, today announced financial results for the second quarter and six months ended June 30, 2006 and recapped certain milestone achievements.
